Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00783952 · ClinicalTrials.gov registry record · NA
Validation of Mixed Venous Blood Oxygen Saturation Obtained With a Novel Mathematical Equation
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00783952: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT00783952 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00783952, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to test a new way to measure the oxygen level in the mixed venous blood system (the system that carries blood collected from all over the body to the heart), which is a very important monitoring tool for the overall oxygen delivery to all our tissues. This new way measures the oxygen level in the mixed venous blood from outside the body, instead of measuring from the inside through a catheter (a thin, flexible plastic tube) that is placed by breaking the skin.
Interventions
- DEVICE Cerebral/Somatic Tissue Oximeter device
- DEVICE Pulmonary artery catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2008-11 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00783952
The ClinicalTrials.gov registry entry for NCT00783952 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cerebral/Somatic Tissue Oximeter device is the first listed.
NCT00783952 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00783952 about?
NCT00783952 is a clinical study titled "Validation of Mixed Venous Blood Oxygen Saturation Obtained With a Novel Mathematical Equation". The purpose of this study is to test a new way to measure the oxygen level in the mixed venous blood system (the system that carries blood collected from all over the body to the heart), which is a very important monitoring tool for the overall oxygen delivery to all our tissues. This new way measur...
What is the current status of trial NCT00783952?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2008-11. Estimated completion is 2013-01.
What interventions are being tested in trial NCT00783952?
The interventions under investigation include: Cerebral/Somatic Tissue Oximeter device (DEVICE), Pulmonary artery catheter (DEVICE).
Who is sponsoring clinical trial NCT00783952?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.